FORMULATION DEVELOPMENT AND EVALUATION OF DILTIAZEM HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLET.

Journal Title: Indo American Journal of Pharmaceutical Research - Year 2017, Vol 7, Issue

Abstract

Abstract The aim of the current study was to design sustained release tablet of Diltiazem hydrochloride and to optimize the drug release profile and dissolution time using response surface methodology. Diltiazem hydrochloride is an antihypertensive drug, a benzothiazepine derivative with vasodilating action. It is prescribed for the treatment of hypertension and other cardiovascular disorder. Antihypertensive should continue for several months. Diltiazem hydrochloride has half-life of 3-4.5 hours. So its chronic use necessitates the sustained release formulation to reduce dose and dosing frequency. A 32 full factorial design (2 factors at 3 levels each) was employed to systematically optimize the drug release profile. Kollidon SR and HPMC K100 were taken as the independent variables. The % drug release at 4 hr and % drug release at 24 hr were dependent variables .Tablets were prepared by direct compression and evaluated for Hardness, Friability, Percent drug content and In-vitro drug release pattern. Both the polymers had significant effect on the drug release and of the tablets. All the formulation release the drug for more than 24 hours. The optimized formulation F6 having Kollidon SR 135mg and HPMC K100 105mg showed maximum release of 98.70 % drug release for 24 hr. Most of the formulation followed Higuchi Model.so sustained release tablet of diltiazem HCl was formed which provide drug release for 24 Hrs.

Authors and Affiliations

D V Derle1, R S Barhate1*, P A Umberkar1, N D Derle2

Keywords

Related Articles

PREVALENCE OF CO-MEDICATION AND POTENTIAL DRUG-DRUG INTERACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY

Abstract Background:-Drug interaction is an important therapeutic challenge among Human Immunodeficiency Virus infected patients. They are often observed in these patients because they frequently receive multiple medicat...

One Pot Synthesis of Substituted Benzothiazoles from substituted aldehydes and 2-aminothiols using Phenyltrimethylammonium tribromide

Substituted 2-phenylbenzo[d]thiazoles were synthesized by stirring a mixture of aldehyde and 2-aminothiol in CH2Cl2 at room temperature using Phenyltrimethylammonium tribromide as a catalyst. We show here that Phenyltrim...

METHOD DEVELOPMENT AND VALIDATION FOR THE ASSAY OF GEMCITABINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC

A simple and precise, rapid and accurate RP-HPLC method has been developed and validated for the determination of gemcitabine hydrochloride in pharmaceutical dosage forms. The chromatographic separation was achieved on k...

FUNCTIONAL OUTCOME OF FEMORAL NECK FRACTURE TREATED BY BIPOLAR HEMIARTHOPLASTY

Abstract To evaluate outcome of neck fracture of the femur grade III and IV when treated by Bipolar hemiarthoplasty in elderly. Total 42 elderly cases were incorporated in study having neck fracture of femur with grade I...

POTENTIAL ANTITUBERCULAR AND SAR STUDY OF SUBSTITUTED [2-(1-BENZOFURAN-2-YL) QUINOLIN-4-YL] METHANOL AND [2-(1-FURAN-2-YL) QUINOLIN-4-YL] METHANOL ANALOGUES

ndicating the importance of coupled heterocycles and their important role in the multitude progress of the diseases. In view of this, a series of [2-(1-benzofuran-2-yl) quinolin-4-yl] methanol and [2-(1-furan-2-yl) quino...

Download PDF file
  • EP ID EP330698
  • DOI -
  • Views 74
  • Downloads 0

How To Cite

D V Derle1, R S Barhate1*, P A Umberkar1, N D Derle2 (2017). FORMULATION DEVELOPMENT AND EVALUATION OF DILTIAZEM HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLET.. Indo American Journal of Pharmaceutical Research, 7(), -. https://europub.co.uk/articles/-A-330698